Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

There are no transmission terms in the subcorpus


Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    Severe immune thrombocytopenic purpura MESHD purpura HP in critical COVID-19: a case report

    Authors: Valérie Lévesque; Émilie Milaire; Daniel Corsilli; Benjamin Rioux-Massé; François Martin Carrier

    doi:10.21203/rs.3.rs-32479/v1 Date: 2020-05-29 Source: ResearchSquare

    Purpose: COVID-19 is a new disease with many undescribed clinical manifestations. Material and methods: We report herein a case of severe immune thrombocytopenic purpura MESHD purpura HP (ITP) in a critical COVID-19 patient.Results: A patient presented a severe episode of immune thrombocytopenia MESHD thrombocytopenia HP (< 10 x 109/L) 20 days after admission for a critical COVID-19. This thrombocytopenia HP thrombocytopenia MESHD was associated with a life-threatening bleeding MESHD. Response to first-line therapies was delayed as it took up to 13 days after initiation of intravenous immunoglobulin and high dose dexamethasone to observe an increase in platelet count. Conclusion: COVID-19 may be associated with late presenting severe ITP. Such ITP may also be relatively resistant to first-line agents. Hematological manifestations of COVID-19, such as the ones associated with life-threatening bleeding MESHD, must be recognized. 

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.